A new four-year project, Research on Scale-up of the Hormonal IUD in New and Emerging Markets (SHINE), will generate evidence to inform the introduction and scale-up of the hormonal IUD and support future introduction of similar family planning methods. The research will be conducted across Kenya, Malawi and Nigeria. The project is led by FHI 360 with funding from the Bill & Melinda Gates Foundation. SHINE will be country-driven by a consortium of partners, with consultation provided by the participating countries’ ministries of health.
This country-led approach will ensure responsiveness to local priorities and will support evidence-based decision-making once results are available.
- Document uptake of the hormonal IUD and the characteristics, deterrents and motivations of users.
- Evaluate cost-efficiency of interventions, including digital options, to build and sustain provider skills and motivation among hormonal IUD service providers.
- Evaluate cost-efficient approaches to build awareness of and demand for the hormonal IUD among potential users, including those who may be attracted to the method’s bleeding profile and/or non-contraceptive health benefits.
The evidence generated through SHINE will help address priority research questions identified by global and country stakeholders and inform other countries considering future introduction of the hormonal IUD and similar family planning methods.
